z-logo
open-access-imgOpen Access
Drug Combos Extend Survival in Colorectal & Liver Cancers
Author(s) -
Mark L. Fuerst
Publication year - 2020
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000656024.93530.49
Subject(s) - bevacizumab , medicine , sorafenib , colorectal cancer , cetuximab , atezolizumab , oncology , hepatocellular carcinoma , quality of life (healthcare) , cancer , chemotherapy , nivolumab , immunotherapy , nursing

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here